FDA LABELING LAWS

It is an FDA violation and Federal offense to print incorrect information on a label, such as stating a product is "Low Glycemic" if it is not. It is an FTC violation to state a product is "Low Glycemic" on brochures, advertisements and product materials if it is not.

Additionally, the physical consequences of diabetics, hypoglycemics, and persons with insulin-related disorders consuming high glycemic products, believing them to be low glycemic, can be profound. Products that claim to be low glycemic, and in reality, are not low glycemic, open themselves to lawsuits for fraud, FDA violations, FTC violations, class action suits, and medical damages.

With clinical evidence of the glycemic properties of a product, manufacturers can provide customers, as well as government agencies, finite proof that their product has been proven to be low glycemic.

The Glycemic Research Institute strictly adheres to FDA and FTC guidelines.